Inventor · disambiguated record
Graham Michael Wynne
Also filed as: WYNNE GRAHAM · WYNNE GRAHAM M · WYNNE GRAHAM MICHAEL
21 granted patents·16 pending applications·226 citations·filing 2001–2016
95Inventor score
Files withWYNNE GRAHAM MICHAEL6ARMER RICHARD EDWARD5OXAGEN LTD4SUMMIT CORP PLC4ATOPIX THERAPEUTICS LTD2
Top patents by PatentIndex Score
37 records- 0196US8268878B2Compounds having CRTH2 antagonist activityARMER RICHARD EDWARD·Filed 2011·Granted Sep 18, 2012·58 cites·5 claims
- 0293US7750027B2Compounds having CRTH2 antagonist activityOXAGEN LTD·Filed 2009·Granted Jul 6, 2010·26 cites·10 claims
- 0390US7999119B2Compounds having CRTH2 antagonist activityOXAGEN LTD·Filed 2007·Granted Aug 16, 2011·14 cites·10 claims
- 0488US8003806B2Integrin antagonists useful as anticancer agentsOSI PHARMACEUTICALS LLC·Filed 2005·Granted Aug 23, 2011·12 cites·8 claims
- 0588US7919512B2Compounds having CRTH2 antagonist activityOXAGEN LTD·Filed 2010·Granted Apr 5, 2011·10 cites·15 claims
- 0688US6504037B2Process for preparing resorcinol derivativesWARNER LAMBERT CO·Filed 2001·Granted Jan 7, 2003·20 cites·9 claims
- 0787US8563536B2Compounds having CRTH2 antagonist activityARMER RICHARD EDWARD·Filed 2011·Granted Oct 22, 2013·8 cites·12 claims
- 0884US8536158B2Compounds having CRTH2 antagonist activityARMER RICHARD EDWARD·Filed 2011·Granted Sep 17, 2013·6 cites·11 claims
- 0984US8518980B2Treatment of Duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2007·Granted Aug 27, 2013·10 cites·4 claims
- 1083US8501713B2Drug combinations for the treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2008·Granted Aug 6, 2013·8 cites·6 claims
- 1182US6949563B2(2-carboxamido)(3-amino)thiophene compoundsWYNNE GRAHAM MICHAEL·Filed 2004·Granted Sep 27, 2005·19 cites·16 claims
- 1281US8975416B2Antibacterial compoundsDAVIS PAUL JAMES·Filed 2009·Granted Mar 10, 2015·5 cites·32 claims
- 1380US8168673B2Compounds having CRTH2 antagonist activityARMER RICHARD EDWARD·Filed 2009·Granted May 1, 2012·7 cites·22 claims
- 1479US8980927B2Compounds having CRTH2 antagonist activityATOPIX THERAPEUTICS LTD·Filed 2013·Granted Mar 17, 2015·3 cites·9 claims
- 1577US9763925B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2016·Granted Sep 19, 2017·2 cites·7 claims
- 1677US9314456B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2015·Granted Apr 19, 2016·2 cites·3 claims
- 1774US7521448B2N-substituted benzimidazolyl c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Apr 21, 2009·9 cites·6 claims
- 1873US6861564B2Process for preparing resorcinol derivativesPFIZER·Filed 2002·Granted Mar 1, 2005·5 cites·7 claims
- 1971US8138351B2Treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2008·Granted Mar 20, 2012·2 cites·10 claims
- 2061US7696225B2(2-carboxamido)(3-Amino) thiophene compoundsOSI PHARM INC·Filed 2004·Granted Apr 13, 2010·0 cites·6 claims
- 2157US2011195929A1Compounds for the treatment of flaviviral infectionsSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 2254US2015246030A1Compounds Having CRTH2 Antagonist ActivityATOPIX THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 2353US2010048660A1Treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2007·Application pending·0 cites
- 2451US2005143594A1Process for preparing resorcinol derivativesFiled 2005·Application pending·0 cites
- 2551US2010022613A1Compounds Having CRTH2 Antagonist ActivityOXAGEN LTD·Filed 2009·Application pending·0 cites
- 2651US2010317607A1Use of compounds for preparing anti-tuberculosis agentsINFECTIOUS DISEASE RES INST·Filed 2008·Application pending·0 cites
- 2750US2009186923A1Compounds Having CRTH2 Antagonist ActivityARMER RICHARD EDWARD·Filed 2009·Application pending·0 cites
- 2849US2012149741A1Treatment of duchenne muscular dystrophyWYNNE GRAHAM MICHAEL·Filed 2008·Application pending·0 cites
- 2946US2010168072A1Drug Combinations for the Treatment of Duchenne Muscular DystrophyBIOMARIN IGA LTD·Filed 2008·Application pending·0 cites
- 3046US2011237538A1Treatment of lysosomal storage disorders and other proteostatic diseasesSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 3145US2014018320A1Treatment of duchenne muscular dystrophySUMMIT CORP PLC·Filed 2013·Application pending·0 cites
- 3245US2014011782A1Drug combinations for the treatment of duchenne muscular dystrophySUMMIT CORP PLC·Filed 2013·Application pending·0 cites
- 3344US2010305120A1Compounds for treating muscular dystrophyBIOMARIN IGA LTD·Filed 2009·Application pending·0 cites
- 3439US2006047123A1Mercaptoamides as histone deacetylase inhibitorsAHMED SALEH·Filed 2005·Application pending·0 cites
- 3532US2014378451A1Cannabinoid-2-Receptor AgonistsISIS INNOVATION·Filed 2012·Application pending·0 cites
- 3626US2017260126A1Squalene compounds as modulators of ldl-receptor expressionUNIV OXFORD INNOVATION LTD·Filed 2015·Application pending·0 cites
- 3724US9822078B2Quinoline compoundsUNIV OXFORD INNOVATION LTD·Filed 2015·Granted Nov 21, 2017·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →